{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:35:59Z","timestamp":1782902159883,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>This review explores clonidine as a potential treatment for agitation across various clinical contexts, focusing on its application in patients with limited cognitive reserve, hyperactive delirium, or conditions where standard treatments may exacerbate underlying symptoms, such as Parkinsonism. The review evaluates the pharmacological properties, efficacy, and practical considerations for using clonidine in managing agitation, including its role in other psychiatric and medical conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Clonidine, a centrally acting alpha-2 adrenergic agonist, reduces norepinephrine release, leading to sedation, anxiolysis, and analgesia without significant respiratory depression. Recent studies and case reports highlight its utility in managing agitation, ADHD, autism spectrum disorders, dementia, and hyperactive delirium. Clonidine has demonstrated advantages over antipsychotics in preserving cognitive function and minimizing delirium duration. Additionally, it shows promise in treating PTSD-related nightmares and as an adjunct in anesthesia and analgesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary\/Takeaway<\/jats:title>\n                    <jats:p>Clonidine offers a well-tolerated, cost-effective alternative to antipsychotics for managing agitation, particularly in vulnerable populations. Its diverse applications, favorable safety profile, and minimal impact on Parkinsonism make it a valuable tool in psychiatry and medicine. Further research is needed to refine dosing protocols and expand its indications in managing agitation and related symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11920-025-01617-5","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T05:26:45Z","timestamp":1750483605000},"page":"464-470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clonidine for Management of Agitation in Delirious Patients"],"prefix":"10.1007","volume":"27","author":[{"given":"Dustin C.","family":"Rowland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Waldvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"1617_CR1","unstructured":"Neerland BE. Delirium in elderly patients: pathophysiological mechanisms and clonidine treatment [dissertation]. Oslo: University of Oslo; 2017."},{"issue":"1","key":"1617_CR2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/geriatrics3010006","volume":"3","author":"G Melegari","year":"2018","unstructured":"Melegari G, Gaspari A, Gualdi E, Gualdi G, Gualdi F, Gualdi M. Delirium in older adults: what a surgeon needs to know. Geriatrics. 2018;3(1):6.","journal-title":"Geriatrics"},{"issue":"8","key":"1617_CR3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/01.CHI.0000046908.27264.00","volume":"42","author":"PL Hazell","year":"2003","unstructured":"Hazell PL, Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad Child Adolesc Psychiatry. 2003;42(8):886\u201394.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"1617_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/WAD.0000000000000456","volume":"36","author":"D Sykora","year":"2022","unstructured":"Sykora D, Stonnington CM, Jain N. An agitated patient with COVID-19 infection and early-onset alzheimer disease. Alzheimer Dis Assoc Disord. 2022;36(1):83.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"8","key":"1617_CR5","first-page":"e17616","volume":"13","author":"Y Albobali","year":"2021","unstructured":"Albobali Y, Shahwan MY, Madi MY, Al-Nuaimi S. Two sisters from Qatar with TUSC3 genetic mutation: psychiatric considerations. Cureus. 2021;13(8):e17616.","journal-title":"Cureus"},{"key":"1617_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpsychires.2021.12.035","volume":"146","author":"M Ahmadpanah","year":"2022","unstructured":"Ahmadpanah M, Pezeshki R, Soltanian AR, Jahangard L, D\u00fcrsteler KM, Keshavarzi A, Brand S. Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance\u2013 Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase. J Psychiatr Res. 2022;146:163\u201371.","journal-title":"J Psychiatr Res"},{"key":"1617_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.12659\/AJCR.908566","volume":"19","author":"A Mohamed","year":"2018","unstructured":"Mohamed A, Mahmoud S, Saad MO, Gazwi K, Elshafei M, Al Anany R. Effectiveness of clonidine in treating Dexmedetomidine withdrawal in a patient with co-existing psychiatric illness: a case report. Am J Case Rep. 2018;19:875.","journal-title":"Am J Case Rep"},{"issue":"5","key":"1617_CR8","first-page":"391","volume":"90","author":"PTSD","year":"2022","unstructured":"PTSD. Anesthesia considerations for the patient with post-traumatic stress disorder. AANA J. 2022;90(5):391\u20136.","journal-title":"AANA J"},{"issue":"1","key":"1617_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1610-8","volume":"21","author":"JG Wang","year":"2017","unstructured":"Wang JG, Belley-Cot\u00e9 E, Burry L, Duffett M, Karachi T, Perri D, et al. Clonidine for sedation in the critically ill: a systematic review and meta-analysis. Crit Care. 2017;21(1):1\u201311.","journal-title":"Crit Care"},{"issue":"2","key":"1617_CR10","first-page":"110","volume":"29","author":"K Banas","year":"2020","unstructured":"Banas K, Sawchuk B. Clonidine as a treatment of behavioural disturbances in autism spectrum disorder: A systematic literature review. J Can Acad Child Adolesc Psychiatry. 2020;29(2):110.","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"issue":"4","key":"1617_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/CNQ.0000000000000172","volume":"40","author":"QM Yeo","year":"2017","unstructured":"Yeo QM, Wiley TL, Smith MN, Hammond DA. Oral agents for the management of agitation and agitated delirium in critically ill patients. Crit Care Nurs Q. 2017;40(4):344\u201362.","journal-title":"Crit Care Nurs Q"},{"issue":"7","key":"1617_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/ajhp\/zxaa013","volume":"77","author":"SS Glaess","year":"2020","unstructured":"Glaess SS, Attridge RL, Gutierrez GG. Clonidine as a strategy for discontinuing Dexmedetomidine sedation in critically ill patients: A narrative review. Am J Health Syst Pharm. 2020;77(7):515\u201322.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"1617_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40360-018-0218-1","volume":"19","author":"KR Hov","year":"2018","unstructured":"Hov KR, Neerland BE, Andersen AM, Undseth \u00d8, Wyller VB, MacLullich AMJ, et al. The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses. BMC Pharmacol Toxicol. 2018;19(1):29.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"1617_CR14","first-page":"8","volume":"23","author":"MA Raskind","year":"2003","unstructured":"Raskind MA, Peskind ER, Kanter ED, Petrie EC, Radant A, Thompson CE, et al. Clonidine use for the treatment of nightmares in posttraumatic stress disorder. J Clin Psychopharmacol. 2003;23(1):8\u201310.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"1617_CR15","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00213-018-4963-z","volume":"235","author":"CI Jahn","year":"2018","unstructured":"Jahn CI, Gilardeau S, Varazzani C, Blain B, Sallet J, Walton ME, Bouret S. Dual contributions of noradrenaline to behavioural flexibility and motivation. Psychopharmacology. 2018;235(9):2687\u2013702.","journal-title":"Psychopharmacology"},{"key":"1617_CR16","doi-asserted-by":"publisher","first-page":"109622","DOI":"10.1016\/j.jclinane.2019.09.016","volume":"61","author":"H Shokri","year":"2020","unstructured":"Shokri H, Ali I. A randomized control trial comparing prophylactic Dexmedetomidine versus clonidine on rates and duration of delirium in older adult patients undergoing coronary artery bypass grafting. J Clin Anesth. 2020;61:109622.","journal-title":"J Clin Anesth"},{"issue":"4","key":"1617_CR17","first-page":"600","volume":"33","author":"D Longrois","year":"2021","unstructured":"Longrois D, Petitjeans F, Simonet O, de Kock M, Belliveau M, Pichot C, et al. How should Dexmedetomidine and clonidine be prescribed in the critical care setting? Rev Bras Ter Intensiva. 2021;33(4):600\u201315.","journal-title":"Rev Bras Ter Intensiva"},{"issue":"1\u20132","key":"1617_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000446441","volume":"98","author":"A Naguy","year":"2016","unstructured":"Naguy A. Clonidine use in psychiatry: panacea or panache? Pharmacology. 2016;98(1\u20132):87\u201392.","journal-title":"Pharmacology"},{"issue":"4","key":"1617_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4103\/1658-354X.177333","volume":"10","author":"V Jannu","year":"2016","unstructured":"Jannu V, Mane RS, Dhorigol MG, Sanikop CS. A comparison of oral Midazolam and oral Dexmedetomidine as premedication in pediatric anesthesia. Saudi J Anaesth. 2016;10(4):390\u20134.","journal-title":"Saudi J Anaesth"},{"issue":"1","key":"1617_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ejpn.2015.10.002","volume":"20","author":"F Jiao","year":"2016","unstructured":"Jiao F, Zhang X, Zhang X, Wang J. Clinical observation on treatment of tourette syndrome in Chinese children by clonidine adhesive patch. Eur J Paediatr Neurol. 2016;20(1):80\u20134.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"1617_CR21","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jcpt.13523","volume":"46","author":"E Purivatra","year":"2021","unstructured":"Purivatra E, Guenette M, Coleman B, Cheung A, Burry L. High-versus low-dose clonidine for sedation and analgesia in critically ill adults: A retrospective cohort study. J Clin Pharm Ther. 2021;46(6):1706\u201313.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"1617_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13063-021-05088-w","volume":"22","author":"OA Fulas","year":"2021","unstructured":"Fulas OA, Laferri\u00e8re A, Ware DMA, Shir Y, Coderre TJ. The effect of a topical combination of clonidine and Pentoxifylline on post-traumatic neuropathic pain patients: study protocol for a randomized, double-blind placebo-controlled trial. Trials. 2021;22(1):149.","journal-title":"Trials"},{"issue":"3","key":"1617_CR23","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12028-019-00741-4","volume":"31","author":"L-OD Koskinen","year":"2019","unstructured":"Koskinen L-OD, Sundstr\u00f6m N, H\u00e4gglund L, Eklund A, Olivecrona M. Prostacyclin affects the relation between brain interstitial glycerol and cerebrovascular pressure reactivity in severe traumatic brain injury. Neurocrit Care. 2019;31(3):494\u2013500.","journal-title":"Neurocrit Care"},{"key":"1617_CR24","unstructured":"Carr A, Ferguson M. What is the evidence to support clonidine as an adjuvant analgesic? Pract Pain Manag 2019;19(5)."},{"issue":"2","key":"1617_CR25","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4103\/joacp.JOACP_248_20","volume":"38","author":"KN Archana","year":"2022","unstructured":"Archana KN, Vyshnavi S, Ganesh V. Effect of caudally administered clonidine on sevoflurane-induced emergence agitation\u2014A randomized trial. J Anaesthesiol Clin Pharmacol. 2022;38(2):196\u2013200.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"1617_CR26","unstructured":"Fast Fact #397. Nonantipsychotics\/Nonbenzodiazepines in the management of agitated delirium. Palliative Care Network of Wisconsin. Published 2020."},{"issue":"3\u20134","key":"1617_CR27","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1093\/milmed\/usaa284","volume":"186","author":"JW Downs","year":"2021","unstructured":"Downs JW, Cumpston KL. Road rash and dizziness: A case of hemodynamically significant topical clonidine toxicity. Mil Med. 2021;186(3\u20134):e451\u20133.","journal-title":"Mil Med"},{"issue":"6","key":"1617_CR28","doi-asserted-by":"publisher","first-page":"e057460","DOI":"10.1136\/bmjopen-2021-057460","volume":"12","author":"BE Neerland","year":"2022","unstructured":"Neerland BE, Busund R, Haaverstad R, Helbostad JL, Landsverk SA, Martinaityte I, et al. Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial. BMJ Open. 2022;12(6):e057460.","journal-title":"BMJ Open"},{"key":"1617_CR29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00134-021-06355-9","volume":"47","author":"L Smit","year":"2021","unstructured":"Smit L, Dijkstra-Kersten SMA, Zaal IJ, van der Jagt M, Slooter AJC. Haloperidol, clonidine and resolution of delirium in critically ill patients: a prospective cohort study. Intensive Care Med. 2021;47:316\u201324.","journal-title":"Intensive Care Med"},{"issue":"12","key":"1617_CR30","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/imj.14287","volume":"49","author":"E Canet","year":"2019","unstructured":"Canet E, Amjad S, Robbins R, Lewis J, Matalanis M, Jones D, Bellomo R. Differential clinical characteristics, management and outcome of delirium among ward compared with intensive care unit patients. Intern Med J. 2019;49(12):1496\u2013504.","journal-title":"Intern Med J"},{"key":"1617_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-015-0006-3","volume":"15","author":"BE Neerland","year":"2015","unstructured":"Neerland BE, Hov KR, Bruun Wyller V, Qvigstad E, Skovlund E, MacLullich AM, Bruun Wyller T. The protocol of the Oslo study of clonidine in elderly patients with delirium; LUCID: a randomised placebo-controlled trial. BMC Geriatr. 2015;15:1\u201314.","journal-title":"BMC Geriatr"},{"key":"1617_CR32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12877-015-0006-3","volume":"15","author":"BE Neerland","year":"2015","unstructured":"Neerland BE, Hov KR, Wyller VB, Qvigstad E, Skovlund E, MacLullich AM, Wyller TB. The Oslo study of clonidine in elderly patients with delirium; LUCID: a randomised placebo-controlled trial. BMC Geriatr. 2015;15:107.","journal-title":"BMC Geriatr"},{"issue":"9","key":"1617_CR33","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1682\/JRRD.2011.10.0202","volume":"49","author":"JE Wielenga-Boiten","year":"2012","unstructured":"Wielenga-Boiten JE, Ribbers GM. Akathisia\u2014rare cause of psychomotor agitation in patients with traumatic brain injury: case report and review of literature. J Rehabil Res Dev. 2012;49(9):1349\u201354.","journal-title":"J Rehabil Res Dev"},{"issue":"11","key":"1617_CR34","first-page":"742","volume":"75","author":"L Ye","year":"2018","unstructured":"Ye L, Lippmann S. Reduction of anxiety after treatment with transdermal clonidine. Bull Am Soc Hosp Pharm. 2018;75(11):742\u20134.","journal-title":"Bull Am Soc Hosp Pharm"},{"key":"1617_CR35","unstructured":"Food US, Administration D. FDA approval of Kapvay (clonidine hydrochloride) extended-release tablets for the treatment of ADHD. FDA. 2010. Available from: https:\/\/www.fda.gov"},{"key":"1617_CR36","doi-asserted-by":"publisher","unstructured":"Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 1999;38(12):1551\u20139. https:\/\/doi.org\/10.1097\/00004583-199912000-00017. PMID: 10596256.","DOI":"10.1097\/00004583-199912000-00017"},{"issue":"3","key":"1617_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.24869\/psyd.2022.612","volume":"34","author":"J Abraham","year":"2022","unstructured":"Abraham J, Varadharajan N, Spalzang ST, Nachiyar S, Menon V. Clonidine in lieu of electroconvulsive therapy (ECT) for control of acute manic excitement amidst the COVID-19 pandemic. Psychiatr Danub. 2022;34(3):612\u20133.","journal-title":"Psychiatr Danub"},{"issue":"2","key":"1617_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2190\/PM.44.2.g","volume":"44","author":"A Alao","year":"2012","unstructured":"Alao A, Selvarajah J, Razi S. The use of clonidine in the treatment of nightmares among patients with co-morbid PTSD and traumatic brain injury. Int J Psychiatry Med. 2012;44(2):165\u20139.","journal-title":"Int J Psychiatry Med"},{"key":"1617_CR39","unstructured":"Wulandari H. Ariani. Post-Traumatic stress disorder following surgery: A case report of A Three-Year-Old child with deep dermal burn injury. Pediatr Sci J. 2020;1(2)."},{"issue":"8","key":"1617_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/ajhp\/zxz021","volume":"76","author":"L Ye","year":"2019","unstructured":"Ye L, Shipley E, Lippmann S. Transdermal clonidine for mitigating posttraumatic stress disorder in an adolescent. Am J Health Syst Pharm. 2019;76(8):487\u20138.","journal-title":"Am J Health Syst Pharm"},{"key":"1617_CR41","unstructured":"Lexicomp C. Drug information. In: UpToDate, Post TW, editor, UpToDate, Waltham, MA. [Accessed 2023]. Available from: https:\/\/www.uptodate.com"},{"issue":"1","key":"1617_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-13-177","volume":"13","author":"MB Patel","year":"2012","unstructured":"Patel MB, McKenna JW, Alvarez JM, Sugiura A, Jenkins JM, Guillamondegui OD, Pandharipande PP. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH after TBI Study): study protocol for a randomized controlled trial. Trials. 2012;13(1):1\u201310.","journal-title":"Trials"},{"issue":"4","key":"1617_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.ejpn.2017.03.003","volume":"21","author":"S Wang","year":"2017","unstructured":"Wang S, Wei YZ, Yang J, Zhou Y, Zheng Y. Clonidine adhesive patch for the treatment of tic disorders: A systematic review and meta-analysis. Eur J Paediatr Neurol. 2017;21(4):614\u201320.","journal-title":"Eur J Paediatr Neurol"},{"key":"1617_CR44","doi-asserted-by":"publisher","first-page":"205031211562176","DOI":"10.1177\/2050312115621767","volume":"3","author":"K Terry","year":"2015","unstructured":"Terry K, Blum R, Szumita P. Evaluating the transition from Dexmedetomidine to clonidine for agitation management in the intensive care unit. SAGE Open Med. 2015;3:2050312115621767. https:\/\/doi.org\/10.1177\/2050312115621767.","journal-title":"SAGE Open Med"},{"key":"1617_CR45","first-page":"195","volume":"28","author":"K Y\u0131ld\u0131r\u0131m","year":"2018","unstructured":"Y\u0131ld\u0131r\u0131m K, D\u00f6nmez YE, Karatoprak S, \u00d6zcan \u00d6. Clonidine use in the treatment of irritability and aggression in adolescents with autism spectrum disorder: three cases. Klinik Psikofarmakol Bul. 2018;28:195\u20136.","journal-title":"Klinik Psikofarmakol Bul"},{"issue":"3","key":"1617_CR46","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/BF00180841","volume":"88","author":"RG Mair","year":"1986","unstructured":"Mair RG, McEntee WJ. Cognitive enhancement in korsakoff\u2019s psychosis by clonidine: A comparison with l-Dopa and ephedrine. Psychopharmacology. 1986;88(3):374\u201380.","journal-title":"Psychopharmacology"},{"issue":"5","key":"1617_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/0004867420945788","volume":"55","author":"S Yadav","year":"2021","unstructured":"Yadav S, Takacs A, Pantelis C, Thomas N. Clonidine induced sexual disinhibition in a patient with treatment-resistant schizophrenia: A case report. Aust N Z J Psychiatry. 2021;55(5):522.","journal-title":"Aust N Z J Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-025-01617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-025-01617-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-025-01617-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:10:30Z","timestamp":1781604630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-025-01617-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1007\/s11920-025-01617-5","relation":{},"ISSN":["1535-1645"],"issn-type":[{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"12 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}